Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

China Fines Eye-Care Companies on Pricing Charges

By Pharmaceutical Processing | May 30, 2014

China has fined Johnson & Johnson, Nikon Corp. and five other makers of eyeglasses and contact lenses on price-fixing charges in its latest effort to use anti-monopoly law to control consumer prices.

Manufacturers were fined a total of 19 million yuan ($3.1 million) for setting minimum prices for retailers and limiting their ability to offer discounts, the Cabinet’s planning agency said Thursday.

Other companies fined included Essilor International SA of France, Germany’s Car Zeiss AG, Hoya Corp. and Bausch + Lomb, owned by Canada’s Valeant Pharmaceuticals International Inc. One Chinese company was fined, Shanghai Weicon Optics Co.

Setting minimum prices is common in some markets to help companies maintain an image as a premium brand. But lawyers say Chinese regulators appear to regard such limits on distributors as illegal.

In August, six suppliers of baby formula were fined a total of $109 million on similar charges.

Investigators have targeted contracts that set minimum retail prices as prohibited “vertical price-fixing” under China’s 2008 anti-monopoly law. Most targets so far have been foreign-owned.

Officials and state media complain foreign suppliers of products from milk to luxury cars overcharge Chinese consumers. Automakers have rejected the accusation, saying higher prices in China are due to import taxes and distribution costs.

The latest investigation began in August after a complaint from the public, the National Development and Reform Commission said.

“Findings showed that some manufacturers had exerted price control on distributors and retailers, which violates anti-monopoly laws,” the agency said on its website.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE